DeepBiome Therapeutics

About:

DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform.

Website: https://www.deepbiometherapeutics.com/

Twitter/X: deepbiome

Top Investors: Scientia Ventures, Boston Angel Club

Description:

DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform. The company's drug discovery platform leverages deep learning, microbiome, and synthetic biology technologies, enabling drug companies to release the therapeutic power of the microbiome. It was founded in 2017 and is based in Allston, Massachusetts.

Total Funding Amount:

$2.51M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Allston, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

contact(AT)deepbiometherapeutics.com

Founders:

Chengwei Luo

Number of Employees:

1-10

Last Funding Date:

2019-07-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai